GlobeNewsWire · AQST · October 15, 2026

Aquestive Therapeutics Announces FDA Acceptance of Anaphylm™ NDA Resubmission and PDUFA Goal Date of March 16, 2027

Get the app for more

Explore stock news, insights and company research.